Activity

The FDA, After 20 Yrs, Has Just Approved A Drug, Endari (L-glutamine), To Combat Sickle Cell Disease In Patients Aged 5 yrs And Older. The Drug Alleviates The Symptoms Associated With The Disease By Making It Possible For The Sickle Cells To Travel Unhindered, Carrying Oxygen, Through The Capillaries And Blood Vessels.

1st Sickle Cell Treatment in Since 1990s, Endari, Approved by FDA

https://sicklecellanemianews.com/2017/07/07/fda-approves-endari-1st-sickle-cell-treatment-in-almost-20-years-for-patients-age-5-and-older/

The FDA approved Endari to treat people with sickle cell disease, ages 5 and older, making available a second treatment for this severe blood disorder.